Welcome to CSNpharm! For Research Use Only!
Home +1-708-781-1677 sales@csnpharm.com    

Histone Methyltransferase

Histone Methyltransferase

Cat. No. Product Name CAS No. Information
CSN17962 XY1   1624117-53-8 XY1 is a negative control of SGC 707 which works as a potent and selective allosteric inhibitor of PRMT3 while XY1 shows almost no activity
CSN17252 WDR5-0103   890190-22-4 WDR5-0103 is a selective antagonist of WD repeat-containing protein 5 WDR5 with Kd of 450 nM
CSN16357 UNC669   1314241-44-5 UNC669 is a selective inhibitor of MBT malignant brain tumor with IC50 of 6 M for L3MBTL1
CSN18843 UNC3866 1872382-47-2 UNC3866 is a high-affinity CBX4 and CBX7 inhibitor with Ki values of 94 and 97 nM respectively
CSN17166 UNC1999 1431612-23-5 UNC1999 is a potent, orally bioavailable and selective inhibitor of EZH2 and EZH1 with IC50 of 2 nM and 45 nM, respectively.
CSN15916 UNC1215 1415800-43-9 UNC1215 is a chemical probe for the methyllysine Kme reader domain of L3MBTL3 with Kd of 120 nM
CSN15901 UNC0646 1320288-17-2 UNC0646 is a potent and selective G9a inhibitor with IC50 of 6 nM
CSN17894 UNC0642 1481677-78-4 UNC0642 is a selective inhibitor of G9aGLP with IC50 of 15 nM
CSN17958 UNC0379 Trifluoroacetate 1620401-83-3 UNC0379 trifluoroacetate is a selective substrate-competitive inhibitor of the lysine methyltransferase SETD8 with IC50 of 7310 M and is selective over 15 other methyltransferases
CSN15846 UNC0379 1620401-82-2 UNC0379 is a selective inhibitor of the lysine methyltransferase SETD8 with IC50 of 73 10 M
CSN17608 UNC0321 1238673-32-9 UNC0321 is a potent and selective G9a inhibitor with Ki of 63 pM UNC0321 is the first G9a inhibitor with picomolar potency and the most potent G9a inhibitor to date
CSN17546 UNC0224 1197196-48-7 UNC0224 is a selective inhibitor of G9a with IC50 of 15 nM
CSN17278 UNC0631 1320288-19-4 UNC 0631 is a potent G9a inhibitor with IC50 value of 4 nM
CSN16351 SGC707 1687736-54-4 SGC707 is a chemical probe of PRMT3 with IC50 of 31 nM
CSN17931 SGC0946 1561178-17-3 SGC0946 is a selective inhibitor of DOT1L methyltransferase with IC50 of 03 nM and can kill mixed lineage leukaemia cells
CSN17964 PFI-2 1627676-59-8 PFI-2 is an a first-in-class potent highly selective and cell-active inhibitor of the methyltransferase activity of SETD7 with IC50 of 2 nM 500 fold active than S-PFI-2
CSN16349 PFI-2 HCl 1627607-87-7 PFI-2 hydrochloride is an a first-in-class potent highly selective and cell-active inhibitor of the methyltransferase activity of SETD7 with IC50 of 2 nM 500 fold active than S-PFI-2
CSN16359 OICR-9429 1801787-56-3 OICR-9429 is an antagonist of the interaction of WDR5 with peptide regions of MLL and Histone 3
CSN18048 MS023 1831110-54-3 MS023 is a potent and selective chemical probe for Type I PRMTs with IC50 values of 30 119 83 8 and 8 nM for PRMTs 1346and 8 respectively MS023 is active in cells
CSN13934 MI-503 1857417-13-0 MI-503 is a small molecule inhibitor of themenin-MLL interaction
CSN17202 MI-463 1628317-18-9 MI-463 is an effective inhibitor of themenin-MLL interaction
CSN17651 MI-3 1271738-59-0 MI-3 is a Menin-MLL interaction inhibitor with IC50 value of 648 25 nM
CSN13507 MI-2   1271738-62-5 MI-2 can inhibits menin-MLL interaction with IC50 of 446 28 nM
CSN17201 MI-136 1628316-74-4 MI-136 can selectively inhibit the interaction of menin and MLL It also suppresses DHT-induced expression of androgen receptor AR target genes
CSN18032 LLY-507 1793053-37-8 LLY-507 is a potent and selective protein-lysine methyltransferase SMYD2 inhibitor with IC50 15 nM which can inhibit p53K370 monomethylation in cells with an IC50 600 nM
CSN17504 HLCL-61 HCl   1158279-20-9 HLCL-61 hydrochloride is an inhibitor of PRMT5 that is used for the treatment of acute myeloid leukemia
CSN17955 GSK591 1616391-87-7 GSK591 is a potent and selective inhibitor of H4 histone methylation by PRMT5MEP50 complex.
CSN15907 GSK343   1346704-33-3 GSK343 is a potent and selective EZH2 inhibitor with IC50 of 4 nM showing 60 fold selectivity against EZH1 and 1000 fold selectivity against other histone methyltransferases
CSN13635 GSK126     1346574-57-9 GSK126 is a potent, highly selective EZH2 methyltransferase inhibitor with IC50 of 9.9 nM, > 1000-fold selective for EZH2 over 20 other human methyltransferases.
CSN16553 GSK503 1346572-63-1 GSK-503 is a selective EZH2 inhibitor with anticancer effect
CSN18855 EPZ020411 HCl 2070015-25-5 EPZ020411 hydrochloride is a potent and selective inhibitor of PRMT6 with IC50 of 10 nM has 10 fold selectivity for PRMT6 over PRMT1 and PRMT8
CSN17943 EPZ011989 Trifluoroacetate 1598383-41-5 EPZ011989 trifluoroacetate is a potent selective orally bioavailable EZH2 inhibitor with Ki 3 nM for EZH2 wt and EZH2 Y646 exhibiting 15-fold selectivity over EZH1 and 3000-fold selectivity over other HMTase
CSN16997 EPZ011989 1598383-40-4 EPZ011989 is a potent selective orally bioavailable EZH2 inhibitor with Ki 3 nM for EZH2 wt and EZH2 Y646 with 15-fold selectivity over EZH1 and 3000-fold selectivity over other HMTase
CSN17168 EPZ005687 1396772-26-1 EPZ005687 is a potent inhibitor of PRC2 with IC50 value of 545nM measured by PRC2 enzymatic activity with selectivity 500-foldoverotherHMTs50-foldoverEZH1 EPZ005687 can specifically inhibit H3K27 methylation
CSN13673 EPZ004777 1338466-77-5 EPZ004777 is a potent selective DOT1L inhibitor with IC50 of 04 nM in a cell-free assay and demonstrates 1200-fold selectivity for DOT1L over all other tested PMTs
CSN13684 EPZ004777 HCl 1380316-03-9 EPZ004777 HCl is a potent selective DOT1L inhibitor with an IC50 of 04 nM in a cell-free assay
CSN13909 EPZ-6438   1403254-99-8 EPZ-6438 is a potent, selective, and orally bioavailable small-molecule inhibitor of EZH2 enzymatic activity with Ki value of 2.5±0.5 nM.
CSN16352 EPZ-5676 1380288-87-8 EPZ-5676 is an aminonucleoside inhibitor of DOT1L with Ki of 80 pM.
CSN17825 EI1 1418308-27-6 EI1 is a selective inhibitor of wild type EZH2 and EZH2 Y641F mutant with IC50 values of 15 nM and 13 nM respectively
CSN17397 CARM1-IN-1 1020399-49-8 CARM1-IN-1 is a potent and specific CARM1 Coactivator-associated arginine methyltransferase 1 inhibitor with IC50 of 86 M and shows very low activity against PRMT1 and SET7 IC50 600 M
CSN12593 C-7280948   587850-67-7 C-7280948 is an inhibitor of PRMT1
CSN13838 BRD4770 1374601-40-7 BRD4770 is an inhibitor of histone methyltransferase G9a with IC50 of 63 M and it can induce cell senescence
CSN15913 BIX-01294 3HCl   1392399-03-9 BIX01294 is an inhibitor of G9a histone methyltransferase with IC50 of 27 M in a cell-free assay reduces H3K9me2 of bulk histones also weakly inhibits GLP primarily H3K9me3 no significant activity observed at other histone methyltransferases
CSN23850 BCI-121 432529-82-3 BCI-121 (BCI121) is a substrate-competitive inhibitor of SMYD3 that inhibits SMYD3-substrate interaction and chromatin recruitment It can significantly reduce the proliferation of various cancer cells.
CSN17412 AZ505 1035227-43-0 AZ505 is a potent and highly selective inhibitor of the oncogenic protein SMYD2 IC50012 M with potential anticancer activity 600 fold than SMYD3 IC50 833 M DOT1L IC50 833 M EZH2 IC50 833 M
CSN13910 Amodiaquin 2HCl 2H2O   6398-98-7 Amodiaquine dihydrochloride is an inhibitor of histamine N-methyltransferase inhibitor with antimalarial and anti-inflammatory activities
CSN12600 AMI-1 20324-87-2 AMI-1 is an inhibitor of protein arginine N-methyltransferases (PRMTs) with IC50 of 8.8 M for PRMT1 via blocking peptide-substrate binding.
CSN17908 A-366 1527503-11-2 A-366 is a peptide-competitive inhibitor of G9aGLP with IC50 of 3 nM
CSN17152 3-Deazaneplanocin A 102052-95-9 3-Deazaneplanocin A is an attractive epigenetic anticancer agent through the inhibition of the cellular enhancer of zeste homolog 2 (EZH2) protein.
CSN13890 3-Deazaneplanocin A HCl 120964-45-6 3-Deazaneplanocin A HCl is a cyclopentanyl analog of 3-deazaadenosine that potently interferes with SAH, a component of the methionine cycle, which causes cellular SAH levels to increase, thus repressing the activity of S-adenosyl-l-methionine–dependent histone lysine methyltransferase activity.
<< PREV 1 2 3 NEXT >>